No association between butyrylcholinesterase K-variant and Alzheimer disease in chinese

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 96, Issue 2, 2000, Pages 167-169

  Lee, D W ^a   Liu, H C ^a   Liu, T Y ^a   Chi, C W ^a   Hong, Chen Jee ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Alzheimer disease; Apolipoprotein; Butyrylcholinesterase

Indexed keywords

AMYLOID; APOLIPOPROTEIN E; CHOLINESTERASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC VARIABILITY; HUMAN; MALE; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; ALZHEIMER DISEASE; BUTYRYLCHOLINESTERASE; CHINA; FEMALE; HUMANS; ISOENZYMES; LINKAGE (GENETICS); MALE; VARIATION (GENETICS);

EID: 0034599501     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(20000403)96:2<167::AID-AJMG8>3.0.CO;2-0     Document Type: Article

References (10)

1. Bartels CF, Jensen FS, Lockridge O, van der Spek AF, Rubinstein HM, Lubrano T, La Du BN. 1992. DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am J Hum Genet 50:1086-1103.
2. Gomez-Ramos P, Moran MA. 1997. Ultrastructural localization of butyrylcholinesterase in senile plaques in the brains of aged and Alzheimer disease patients. Mol Chem Neuropathol 30:161-173.
3. Hong CJ, Liu TY, Liu HC, Wang SJ, Fuh JL, Chi CW, Lee KY, Sim CB. 1996. e4 allele of apolipoprotein E increase risk of Alzheimer's disease in a Chinese population. Neurology 46:1749-1751.
4. Jensen FS, Nielsen LR, Schwartz M. 1996. Detection of the plasma cholinesterase K variant by PCR using an amplification-created restriction site. Hum Hered 46:26-31.
5. Jensen FS, Schwartz M, Viby-Mogensen J. 1995. Identification of human plasma cholinesterase variants using molecular biological techniques. Acta Anaesthesiol Scand 39:142-149.
6. Lawrence AD, Sahakian BJ. 1998. The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems. Neurochem Res 23: 787-794.
7. Lehmann DJ, Johnston C, Smith AD. 1997. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Hum Mol Genet 6:1933-1936.
8. Maekawa M, Sudo K, Dey DC, Ishikawa J, Izumi M, Kotani K, Kanno T. 1997. Genetic mutations of butyrylcholine esterase identified from phenotypic abnormalities in Japan. Clin Chem 43:924-929.
9. Mckhann GD, Drachman M, Folstein R, Katzman R, Price D, Stadlan ZM. 1984. Clinical diagnosis of Alzheimer's disease. Neurology 34:939-944.
10. Shen ZX. 1996. The significance of the activity of CSF cholinesterases in dementias. Med Hypotheses 47:363-376.